Biosimilars: US FDA Heralds The End Of Switching Studies For Interchangeability

 
• By David Wallace
  
Red on off switch
The FDA is switching off the requirement for switching studies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics